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Abstract Article Info 
Introduction: Nasopharyngeal carcinoma is the most common head and neck malignant tumor in Indonesia 
(60%), followed by malignant nasal and paranasal sinuses (18%), and larynx (16%).  Prevention of 
Nasopharyngeal Carcinoma is still a problem; this is because the etiology is still uncertain; early symptoms are 
not typical. 
Objective: The primary objective of this study was to review nasopharyngeal carcinoma cases based on gender, 
stage, ethnicity, and complaints in Wahidin Sudirohusodo hospital. 
Methods: This was a retrospective study to review the case of nasopharyngeal carcinoma in Wahidin 
Sudirohusodo hospital from January 2011 to June 2019 with total samples of 280 cases. Samples were taken 
from medical records, and the data about gender, ethnicity, stage of the tumor, and complaints were collected. 
Results: Complaints felt by patients were generally due to a neck lump in 175 cases (62.5%), Blood staine rinore 
45 cases (16%), tinnitus 25 cases (8.9%), cephalgia 5 cases (1 7%). Comparison of patients with nasopharyngeal 
carcinoma according to sex, men compared with women 2:1, namely men 188 cases (67.14%) and women 92 
cases (32.86%). The origin of the nasopharyngeal carcinoma patients was the Bugis-Makassar tribe 178 cases 
(63.57%), the Toraja tribe as many as 32 cases (11.43%), Java 10 cases (3.57%), Mandar 4 cases (1.43%), others 
56 cases (20%). The stages of the nasopharyngeal carcinoma were stage IV 160 cases (57.14%), stage III 57 
cases (20.36%), stage II 49 cases (17.5%), stage I 14 cases (5%).  
Conclusion: 280 cases of nasopharyngeal carcinoma have been treated with a male ratio of 188 people: 92 
women or 2: 1, this is the same as previous studies. The youngest age is found at 9 years as many as 3 people. 
The youngest age ever reported in Semarang is 4 years. Furthermore, most cases come in stage IV. 
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Nasopharyngeal carcinoma is the most common head and neck malignant 
tumor in Indonesia (60%) followed by malignant nasal and paranasal sinuses 
(18%) and larynx (16%). A survey conducted by the Department of Health on a 
"pathology-based" basis has a prevalence rate of 4.7 nasopharyngeal carcinomas 
per 100,000 population or an estimated 7000-8000 cases per year throughout 
Indonesia. In Indonesia, the incidence of KNF is almost evenly distributed in 
every region; in Cipto Mangunkusumo Hospital (RSCM) Jakarta, more than 100 
cases were found a year, Hasan Sadikin Hospital Bandung 60 cases, Makassar 
25 cases, Palembang 25 cases, Denpasar 15 cases and 11 cases in Padang and 
Bukit Tinggi. This malignancy is caused by 3 important etiological factors, 
namely the involvement of the Epstein-Barr Virus (EBV), genetic determination, 
and the environment [1-3]. 
Prevention of Nasopharyngeal Carcinoma is still a problem, this is 
because the etiology is still uncertain, early symptoms are not typical, and the 
location of the nasopharynx is hidden, so the diagnosis is often late [4]. A 
retrospective review of Nasopharyngeal Carcinoma in the RSUP Dr. Wahidin 
Sudirohusodo Makassar found 280 cases. The youngest sufferers are 9 years 
old and the most are in the fourth decade. 
The nasopharynx is a cavity with a rigid wall above, behind, and laterally 
which anatomically belongs to the pharynx. To the anterior contact with the nasal 
cavity through the koana and the back edge of the rice septum, so nasal 
obstruction is a disorder that often arises. Posteriorly the nasopharyngeal wall 
curves supero-anteriorly and lies below the sphenoid os. At the same time, the 
back of the nasopharynx is bordered by the retrofaring space, pre vertebral fascia 
and the muscles of the pharyngeal wall. In the lateral wall of the nasopharynx is 
located Eustachian tube orifice where the orifice is bounded superior and 
posterior to the torus tubarius, so that the spread of the tumor laterally will cause 
blockage of the eustaculous tubal orifice and will interfere with hearing. Towards 
the posterosuperior torus tubarius lies the Rosenmuller fossa, which is the most 
common location of nasopharyngeal carcinoma [5, 6]. 
Nasopharyngeal carcinoma (KNF) is a unique tumor due to its etiology 
and endemic distribution. Ethnic and regional factors also influence the risk 
of disease. The incidence of NPC differs geographically and ethnically and 
is related to the Epstein-Barr Virus (EBV) [1-3]. Globally, in 2000 there 
were approximately 65,000 new cases and 38,000 deaths caused by this 
disease. In some countries, the incidence of cancer is only 0.6% of all 
malignancies. In America, the incidence of NPC is 1-2 cases per 100,000 
men and 0.4 cases per 100,000 women. Nevertheless, in other countries and 
certain ethnic groups, such as in China, Southeast Asia, North Africa, 
malignant tumors are often found [1, 4]. 
Patients with nasopharyngeal carcinoma are more often found in men 
than in women with a ratio of 2-3: 1. This disease is found mainly in the 
productive age (30-60 years), with the most age is 40-50 years [1, 3]. There 
are three etiological factors, namely Epstein-Barr virus infection, genetic 
vulnerability, and environmental factors that play a role in the high 
incidence of NPC [1, 3, 4, 7]. 
Establishing a diagnosis of NPC is the most important thing in reducing 
mortality from this disease. Early symptoms include ear and nose symptoms 
[8, 9]. Ear Symptoms: eustachian tube, hearing disorders, serous otitis media 
to tympanic membrane perforation, Tinnitus, Otalgia, and Nasal Symptoms: 
epistaxis, nasal obstruction. On the other hand, advanced Symptoms are 
cervical lymphadenopathy, Neurological Symptoms [8, 9]. 
In 1978, WHO proposed a NPC classification based on the concepts of 
Shanmugartman and Sobin. According to WHO, NPC is divided into 3 types, 
namely [10, 11]: 1) WHO Type I: Keratinizing Squamous Carcinoma, This type 
is defined by distinguishing squamous cell carcinoma or transition with keratin 
production; 2) WHO Type II: Non-keratinizing carcinoma; WHO Type III: 
Undifferentiated Carcinoma including lymphoepithelioma. The shape consists of 
cells malignant epithelium with lymphocytic infiltration. 
 
 







In 1991, WHO re-classified the NPC level [10, 11]: 1) Squamous Cell 
Carcinoma with the subtype Keratinizing Squamoud Cell Carcinoma; 2) 
Non-keratinizing Squamous Cell Carcinoma which is divided into 
Differentiated and Undifferentiated. 
Types without differentiation and without keratinization NPC (WHO 
types 2 and 3) have the same properties, which are radiosensitive. At the 
same time, the type with keratinization is not so radiosensitive [10, 11]. 
If suspicion is found that leads to nasopharyngeal carcinoma, the 
protocol below can help to establish a definitive diagnosis and stage of the 
tumor [12]: 1) history and physical examination; 2) laboratory examination; 
3) nasopharyngeal biopsy; 4) anatomical pathology examination; 5) 
radiological examination; 6) neuro-ophthalmology examination; 7) 
serological examination. 
Radiotherapy has been the primary therapeutic modality for NPC 
for many years. This is because the nasopharynx is close to the 
important structure and nature of the KNF infiltrate, making surgery 
difficult for the primary tumor. NPC is generally inoperable, more 
responsive to radiotherapy and chemotherapy than other malignant head 
and neck tumors [1, 13]. 
The two types of non-keratinizing KNF (WHO types 2 and 3) are 
radiosensitive, and radiotherapy is therefore the main management 
component. The target of radiotherapy management is based on the 
expansion of the tumor at the start of the diagnosis, without paying attention 
to the reduction in tumor size after neoadjuvant chemotherapy [13, 14]. 
Cytotoxic drugs in chemotherapy have a primary effect on the 
synthesis or macroeconomic function, which affects DNA, RNA, or 
proteins that play a role in the growth of cancer cells so that cancer cells 
die. From various studies known, cell death does not occur when cells are 
exposed to drugs. Often a cell must go through several stages of division 
before then die. Because only a portion of cells dies due to the drugs 
given, repeated doses of chemotherapy must continue to be given to 
reduce the number of cancer cells present [13].  
During therapy, patients should be examined regularly by 
radiotherapists and surgeons. Slow complications consist of a dry oral cavity 
and the effect of radiation on the underlying bone. For that, patients who 
will get radiation, especially in the mandible, should get a complete dental 
examination. Any tooth that is doubtful of its durability should be removed, 
and the wound must heal before the start of radiation therapy. Careful 
fluoride and oral hygiene treatment can prevent complications such as 
osteomyelitis. Young people who receive radiation therapy should be 
followed closely throughout their lives to detect the possibility of late 
development of malignancy in areas that are receiving radiation [15]. 
Staging is the only strong predictor for overall survival. Patients with 
intracranial extension have low survival which represents an advanced stage 
of the disease. In addition, smoking status has poor prognostic value for 
survival in NPC patients. Survival correlates well with histological variants 
of NPC with better survival for radio responsive non-keratinizing and 
undifferentiated variants [16].  
2. MATERIALS AND METHODS 
The material was taken from the patient's status in the medical records 
of RSUP Dr. Wahidin Sudirohusodo with a malignant nasopharyngeal tumor 
period January 2011 - June 2019 found 280 cases. A definitive diagnosis is 
made by biopsy. Histopathological examination results showed a malignant 
nasopharyngeal tumor. 
3. RESULTS 
There are several ways to determine the NPC stage. The latest method 
of determining NPC stage is according to the 7th edition of the American 










Table 1. Nasopharyngeal Carcinoma Classification [1,3] 
Tumors in the nasopharynx (T) 
TX Primary tumors cannot be assessed 
TO No tumor was seen 
Tis Carsinoma in situ 
T1 
 
Primary tumors are confined to the nasopharynx, or extend to the oropharynx 
and/or cavity rice without expansion to the parafaring region. 
T2 
 




Tumor involving bone and/or paranasal sinus. 
T4 Tumors extend intracranially and/or involve the cranial nerve, hypopharynx, 
orbit, or extension to the infratemporal fossa/masticator space. 
Regional lymph nodes (N) 
NX The KGB Region cannot be assessed 
NO There is no metastasis to the KGB 
Nl 
 
Metastasis to unilateral KGB, size 6 cm or less than 6 cm with dimensions 
larger, located above the supraclavicular fossa, and unilateral or bilateral, 
Retrofaringeal KGB, 6 cm or less with larger dimensions. 
N2 
 
Metastasis to bilateral KGB, size 6 cm or less than 6 cm with Dimensions the 
larger, located above the supraclavicular fossa. 
N3 Metastasis to KGB> 6 cm and or in the supraclavicular fossa 
N3a KGB size> 6 cm 
N3b Located in the supraclavicular fossa. 
Distant Metastasis (M) 
M0 There is no distant metastasis 
M1 Distant metastases 
Table 2. NPC stage according to the AJCC [1, 3] 






























































































The classification of NPC based on the 7th edition of the American Joint 
Committee on Cancer in 2010 support the author to determine and analyze 
the data. The result are showing up in this research as captured in the next 
tables. 
Table 3. Gender classification 
Gender       Cases Percentage (%) 
Male 188 67% 
Female 92 33% 
Based on table 3, it can be seen that the number of male cases was 188 
(67%) and female cases were 92 cases (33%) from total 280 cases.  
Table 4. Age classification 
Age Range          Total Percentage (%) 
<20 years 7 3% 
21-30 years 25 9% 
31-40 years 62 22% 
41-50 years 68 24% 
>51 years 116 42% 
Based on table 4, the highest number of cases was over 50 years, namely 
116 cases (42%), followed by 68 cases (24%) aged 41-50 years, 62 cases 
(22%) aged 31-40 years, 21-30 years old were 25 cases (25%), and less than 
20 years old were 7 cases (3%). 
Table 5. Ethnics classification 
Ethnics        Total Percentage (%) 
Bugis– Makassar  178 64% 
Toraja 32 11% 
Jawa 10 4% 
Mandar  4 1% 
Lain-lain 56 20% 







Based on table 5, the highest number of nasopharyngeal carcinoma 
cases were found in the Bugis-Makassar tribe, namely 178 cases (64%), the 
Toraja tribe as many as 32 cases (11%), the Javanese as many as 10 cases 
(4%), the Mandar tribe as many as 4 cases ( 1%), other ethnic groups as 
many as 56 cases (20%). 
Table 6. Symptoms classification 
Symptoms           Total            Percentage(%) 
Neck Lump 175 62% 
Tinnitus 25 9% 
Cephalgia 5 2% 
Blood Stained Rhinorrhea 45 16% 
Nose Bleed 30 11% 
Based on table 6, the most common symptoms were neck lump, namely 
175 cases (62%), tinnitus as many as 25 cases (9%), cephalgia as many as 5 
cases (2%), Blood Stained rhinorrhea as many as 45 cases (16%), nose bleed 
as many as 30 cases (11%). 
Table 7. Stages classification 
Stages         Total          Percentage(%) 
Stage I 14 5% 
Stage II 49 18% 
Stage III 57 20% 
Stage IV 160 57% 
Based on table 7, total cases of nasopharyngeal carcinoma in stage IV 
were 160 cases (57%), stage III was 57 cases (20%), stage II was 49 cases 
(18%), and stage I was 14 cases (5%). 
4. DISCUSSION 
Retrospective research was conducted by researchers for 9 years (2011-
2019) at the General Hospital. Dr. Wahidin Sudirohusodo found 280 cases of 
nasopharyngeal carcinoma. By gender, the number of male cases was 188 (67%), 
and female cases were 92 cases (33%) from total 280 cases. This study is in line 
with previous studies and epidemiological data (Saragih AR) that the ratio 
between men and women in cases of nasopharyngeal carcinoma is 2-3: 1 
By age, the highest number of cases was over 50 years, namely 116 cases 
(42%), followed by 68 cases (24%) aged 41-50 years, 62 cases (22%) aged 31-
40 years, 21-30 years old were 25 cases (25%), and less than 20 years old were 
7 cases (3%). This study is in line with previous studies and epidemiological data 
(Saragih AR) that most cases of nasopharyngeal carcinoma occurs in the 4th and 
5th decades of age. 
Based on tribes, the highest number of nasopharyngeal carcinoma cases 
were found in the Bugis-Makassar tribe, namely 178 cases (64%), the Toraja tribe 
as many as 32 cases (11%), the Javanese as many as 10 cases (4%), the Mandar 
tribe as many as 4 cases ( 1%), other ethnic groups as many as 56 cases (20%). 
This occurs because the Bugis-Makassar tribe is the largest population in 
Makassar City and is the original inhabitant of the city of Makassar. 
Based on the symptoms, the most common symptoms were neck lump, 
namely 175 cases (62%), tinnitus as many as 25 cases (9%), cephalgia as many 
as 5 cases (2%), Blood Stained rhinorrhea, as many as 45 cases (16%), nose bleed 
as many as 30 cases (11%). Moreover, based on stages, total cases of 
nasopharyngeal carcinoma in stage IV were 160 cases (57%), stage III was 57 
cases (20%), stage II was 49 cases (18%), and stage I was 14 cases (5%). This 
data shows that there is still a lack of public knowledge about nasopharyngeal 
carcinoma, especially in the city of Makassar, so that the patient goes to the 
hospital after a lump in the neck indicates that the patient is in an advanced stage 
(stage III and IV). Initial symptoms of nasopharyngeal carcinoma are not typical, 
so they generally come at an advanced stage. 
5. CONCLUSION 
The conclusion of the study is the classification for 9 years old, 280 
cases of nasopharyngeal carcinoma have been treated with a male ratio of 
188 people and 92 women or 2: 1, this is the same as previous studies. Total 
cases with the most age found in patients with nasopharyngeal carcinoma 
over 50 years. Lack of public knowledge in Makassar and atypical early 
symptoms made the patient come to the hospital at an advanced stage 
(mostly at stage IV). 
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